Two Discs Carry Gtx Hopes to Fda -- After Years of Research, Tons of Money, Memphis Firm Applies to Sell Acapodene
The Commercial Appeal (2007-Current) › January 06, 2009
Linked as:
Summary
Last week, two electronic discs packed with data arrived at a Food and Drug Administration office in Beltsville, Md.
With that, Memphis-based pharmaceutical company GTx Inc. filed its first-ever application for federal approval to sell a new drug.See the full content of this document
Extract
Two Discs Carry Gtx Hopes to Fda -- After Years of Research, Tons of Money, Memphis Firm Applies to Sell Acapodene
The discs represented the culmination of years of study that aim to prove the experimental prostate cancer drug Acapodene is safe and effective in an 80 milligram dose.
If the FDA appro...See the full content of this document
Sponsored links
